BRIEF published on 08/29/2025 at 16:20, 1 year ago The Vanguard Group, Inc. Discloses Position in American Axle & Manufacturing Securities Takeover Code Vanguard Group Stake Disclosure American Axle
PRESS RELEASE published on 08/29/2025 at 16:20, 1 year ago Form 8.3 - The Vanguard Group, Inc.: ADRIATIC METALS PLC-CDI The Vanguard Group, Inc. discloses a 0% interest in Adriatic Metals plc. Deals 5,070,593 shares at 6.22 AUD each Shares Disclosure The Vanguard Group Deals Adriatic Metals Plc
BRIEF published on 08/29/2025 at 16:19, 1 year ago The Vanguard Group Discloses Interests in Mural Oncology Ordinary Shares Irish Takeover Panel The Vanguard Group Shareholding Disclosure Mural Oncology
BRIEF published on 08/29/2025 at 16:18, 1 year ago Vanguard Group Discloses Position in Empiric Student Property Ordinary Shares Disclosure Takeover Code Vanguard Group Empiric Student Property
BRIEF published on 08/29/2025 at 16:17, 1 year ago The Vanguard Group Discloses Position in Unite Group plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Unite Group Plc
BRIEF published on 08/29/2025 at 16:16, 1 year ago The Vanguard Group Discloses Stake in Spirent Communications Takeover Code Shareholding Stake Disclosure Vanguard Spirent Communications
PRESS RELEASE published on 08/29/2025 at 16:15, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated Vanguard Group discloses 10.68% stake in Qualcomm Inc. through Form 8.3 filing. Public position disclosure for relevant securities Form 8.3 Relevant Securities Position Disclosure Vanguard Group Qualcomm Inc.
PRESS RELEASE published on 08/29/2025 at 16:15, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.54% stake in American Axle & Manufacturing Holdings, Inc. as of 28 August 2025 Vanguard Group Stake Disclosure Financial Holdings Investment Disclosure American Axle
PRESS RELEASE published on 08/29/2025 at 16:14, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses ownership of 4.47% in Mural Oncology plc. No other parties involved in the disclosure. Details of the transaction included The Vanguard Group Ownership Disclosure Financial Disclosure Transaction Details Mural Oncology Plc
PRESS RELEASE published on 08/29/2025 at 16:13, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc The Vanguard Group, Inc. discloses a 1.90% stake in Empiric Student Property plc. Purchase of 57,743 securities at 0.92 GBP per unit The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Empiric Student Property Plc
Published on 09/12/2026 at 02:35, 1 day 20 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 1 hour ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 6 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 5 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 15 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 1 hour ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 3 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 3 hours ago Availability of the 2026 Interim Financial Report
